Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 1.445 0.35% 0.01
TENX closed down 4.0 percent on Friday, May 29, 2020, on 1.3 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical TENX trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bullish Bullish Swing Setup 0.35%
Calm After Storm Range Contraction 0.35%
Upper Bollinger Band Walk Strength 0.35%
Inside Day Range Contraction 0.35%
Wide Bands Range Expansion 0.35%
Overbought Stochastic Strength 0.35%
Upper Bollinger Band Touch Strength 0.35%
Expansion Breakout Bullish Swing Setup -3.67%
Pocket Pivot Bullish Swing Setup -3.67%
Volume Surge Other -3.67%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Medicine Pharmaceutical Pharmaceutical Products Pharmacology Cardiac Surgery Topical Medication Traumatic Brain Injury Wound Healing

Is TENX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.77
52 Week Low 0.25
Average Volume 356,876
200-Day Moving Average 1.10
50-Day Moving Average 0.73
20-Day Moving Average 0.95
10-Day Moving Average 1.22
Average True Range 0.15
ADX 48.02
+DI 46.05
-DI 3.25
Chandelier Exit (Long, 3 ATRs ) 1.32
Chandelier Exit (Short, 3 ATRs ) 1.05
Upper Bollinger Band 1.54
Lower Bollinger Band 0.37
Percent B (%b) 0.92
BandWidth 122.90
MACD Line 0.20
MACD Signal Line 0.14
MACD Histogram 0.0594
Fundamentals Value
Market Cap 40.66 Million
Num Shares 28.2 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -1.01
Price-to-Sales 0.00
Price-to-Book 1.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.70
Resistance 3 (R3) 1.71 1.64 1.65
Resistance 2 (R2) 1.64 1.58 1.63 1.64
Resistance 1 (R1) 1.54 1.53 1.51 1.53 1.62
Pivot Point 1.47 1.47 1.45 1.46 1.47
Support 1 (S1) 1.37 1.41 1.34 1.36 1.26
Support 2 (S2) 1.30 1.36 1.29 1.24
Support 3 (S3) 1.20 1.30 1.23
Support 4 (S4) 1.19